BRIM Biotechnology, Inc. (TPE:6885)
Taiwan
· Delayed Price · Currency is TWD 22.95
-0.15 (-0.65%)
At close: Apr 28, 2026
BRIM Biotechnology Market Cap
BRIM Biotechnology has a market cap or net worth of 3.06 billion as of April 28, 2026. Its market cap has decreased by -8.12% in one year.
Market Cap
3.06B
Enterprise Value
2.01B
Revenue
5.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.95
Market Cap Chart
Since June 23, 2022, BRIM Biotechnology's market cap has increased from 1.77B to 3.06B, an increase of 73.12%. That is a compound annual growth rate of 15.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3.06B | -22.86% |
| Dec 31, 2025 | 3.96B | -2.58% |
| Dec 31, 2024 | 4.07B | 17.34% |
| Dec 29, 2023 | 3.47B | -2.55% |
| Dec 30, 2022 | 3.56B | 101.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HeXun Biosciences | 2.96B |
| SYN-TECH Chem. & Pharm. | 3.16B |
| Apex Biotechnology | 2.88B |
| Shine-On BioMedical | 3.30B |
| Syngen Biotech | 2.82B |
| Intech Biopharm | 3.32B |
| Genovate Biotechnology | 3.35B |
| 3D Global Biotech | 2.77B |